This brand name is authorized in Japan, Singapore
The drug MYONAL contains one active pharmaceutical ingredient (API):
1
Eperisone
UNII U38O8U7P6X - EPERISONE HYDROCHLORIDE
|
Eperisone is an antispastic agent used for treatment of diseases characterized by muscle stiffness and pain. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
MYONAL Tablets / Granules | MPI, US: SPL/PLR |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
M03BX09 | M Musculo-skeletal system → M03 Muscle relaxants → M03B Muscle relaxants, centrally acting agents → M03BX Other centrally acting agents | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 1249009D1030, 1249009F1090 |
Country: SG | Health Sciences Authority | Identifier(s): 06292P |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.